https://doi.org/10.4081/monaldi.2026.3230
Mapping the nexus: tracing blood pressure changes in patients with psoriasis
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Published: 6 May 2026
Psoriasis is a chronic condition driven by genetics, immune dysfunction, and environmental factors, impacting the skin, nails, joints, and potentially more. Understanding the correlation between psoriasis severity and blood pressure is crucial for mitigating the risk of cardiovascular comorbidities in affected patients. The aim of the study was to analyze the correlation between blood pressure and the duration and severity of psoriasis in affected patients. This is a cross-sectional study that included 150 subjects (100 psoriasis patients and 50 controls). After thorough history taking and complete general physical and dermatological examinations, the patients were divided into various grades of severity of the disease based on the Psoriasis Area Severity Index. Blood pressure of all subjects was measured. Patients with psoriasis have significantly higher levels of both systolic blood pressure and diastolic blood pressure than the controls (p=0.003 and p<0.001, respectively). A linear positive correlation was found between the systolic blood pressure (R²=0.768) and diastolic blood pressure (R²=0.550) and the duration of the disease. Similarly, a significant linear positive correlation was found between the severity of the disease and systolic blood pressure (R²=0.196) and also the diastolic blood pressure (R²=0.119). Multivariate regression analysis confirmed that disease severity and duration independently predict elevated blood pressure (p<0.05). This study establishes the association of psoriasis with increased blood pressure and its correlation with severity and duration, shedding light on the complex relationship between the disease and cardiovascular health.
Downloads
Dogra S, Yadav S. Psoriasis in India: prevalence and pattern. Indian J Dermatol Venereol Leprol 2010;76:595-601. DOI: https://doi.org/10.4103/0378-6323.72443
Alexis AF, Blackcloud P. Psoriasis in skin of color: epidemiology, genetics, clinical presentation, and treatment nuances. J Clin Aesthetic Dermatol 2014;7:16-24.
Xhaja A, Shkodrani E, Frangaj S, et al. An epidemiological study on trigger factors and quality of life in psoriatic patients. Mater Sociomed 2014;26:168-71. DOI: https://doi.org/10.5455/msm.2014.26.168-171
Branisteanu DE, Nicolescu AC, Branisteanu DC, et al. Cardiovascular comorbidities in psoriasis (review). Exp Ther Med 2022;23:152. DOI: https://doi.org/10.3892/etm.2022.11124
Hu SC, Lan CE. Psoriasis and cardiovascular comorbidities: focusing on severe vascular events, cardiovascular risk factors and implications for treatment. Int J Mol Sci 2017;18:2211. DOI: https://doi.org/10.3390/ijms18102211
Ridker PM. Psoriasis, inflammation, and vascular risk: a problem more than skin deep? Eur Heart J 2010;31:902-4. DOI: https://doi.org/10.1093/eurheartj/ehq042
Ena P, Madeddu P, Glorioso N, et al. High prevalence of cardiovascular diseases and enhanced activity of the reninangiotensin system in psoriatic patients. Acta Cardiol 1985;40:199-205.
Kaye JA, Li L, Jick SS. Incidence of risk factors for myocardial infarction and other vascular diseases in patients with psoriasis. Br J Dermatol 2008;159:895-902. DOI: https://doi.org/10.1111/j.1365-2133.2008.08707.x
Kaushik A, Chopra D, Kaur K, et al. Serum adiponectin levels as an independent marker of severity of psoriasis: a cross-sectional analysis. J Psoriasis Psoriatic Arthritis 2023;8:148-55. DOI: https://doi.org/10.1177/24755303231199995
Farber EM, Nall ML. The natural history of psoriasis in 5,600 patients. Dermatologica 1974;148:1-18. DOI: https://doi.org/10.1159/000251595
Pietrzak A, Bartosinska J, Chodorowska G, et al. Cardiovascular aspects of psoriasis: an updated review. Int J Dermatol 2013;52:153-62. DOI: https://doi.org/10.1111/j.1365-4632.2012.05584.x
Siegel D, Devaraj S, Mitra A, et al. Inflammation, atherosclerosis, and psoriasis. Clin Rev Allergy Immunol 2013;44:194-204. DOI: https://doi.org/10.1007/s12016-012-8308-0
Biyik I, Narin A, Bozok MA, Ergene O. Echocardiographic and clinical abnormalities in patients with psoriasis. J Int Med Res 2006;34:632-9. DOI: https://doi.org/10.1177/147323000603400608
Gill P, Tang MM, Jamil A, et al. Cardiac abnormalities in psoriasis. Notice Aut 2017;8:25-42.
Mohaseb AI, El-Farargy SM, Yasien HA, Ghanayem NM. Correlation between psoriasis area severity index score and metabolic syndrome in psoriatic patients of Menoufia University. Menoufia Med J 2021;34:896-901.
Gunes Y, Tuncer M, Calka O, et al. Increased frequency of pulmonary hypertension in psoriasis patients. Arch Dermatol Res 2008;300:435-40. DOI: https://doi.org/10.1007/s00403-008-0859-9
Bacaksiz A, Erdogan E, Tasal A, et al. Electrocardiographic P-wave characteristics in patients with psoriasis vulgaris. Ups J Med Sci 2013;118:35-41. DOI: https://doi.org/10.3109/03009734.2012.744372
Armstrong AW, Azizi S, Wu J, et al. Psoriasis, electrocardiographic characteristics, and incidence of atrial fibrillation. Arch Dermatol Res 2013;305:891-7. DOI: https://doi.org/10.1007/s00403-013-1419-5
Simsek H, Sahin M, Akyol A, et al. Increased risk of atrial and ventricular arrhythmia in long-lasting psoriasis patients. ScientificWorldJournal 2013;2013:901215. DOI: https://doi.org/10.1155/2013/901215
Kumar U, Agrawal M, Varma K, et al. Study of P-wave dispersion in patients of psoriasis: An observational study. IP Indian J Clin Exp Dermatol 2023;9:66-71. DOI: https://doi.org/10.18231/j.ijced.2023.012
Calapkorur B, Kelesoglu S, Sarli B, et al. Atrial electromechanical delay is impaired in patients with psoriasis. Med Princ Pract 2015;24:30-5. DOI: https://doi.org/10.1159/000365760
Dattilo G, Imbalzano E, Casale M, et al. Psoriasis and cardiovascular risk: correlation between psoriasis and cardiovascular functional indices. Angiology 2018;69:31-7. DOI: https://doi.org/10.1177/0003319717699329
Gorga E, Scodro M, Valentini F, et al. Echocardiographic evaluation of diastolic dysfunction in young and healthy patients with psoriasis: a case-control study. Monaldi Arch Chest Dis 2018;88:934. DOI: https://doi.org/10.4081/monaldi.2018.934
Aryanian Z, Jafaripour I, Kohneshin E, et al. Echocardiographic and electrocardiographic assessments in patients with psoriasis. Caspian J Intern Med 2021;12:162-6.
Sowers JR. Hypertension, angiotensin II, and oxidative stress. N Engl J Med 2002;346:1999-2001. DOI: https://doi.org/10.1056/NEJMe020054
Armstrong AW, Voyles SV, Armstrong EJ, et al. Angiogenesis and oxidative stress: common mechanisms linking psoriasis with atherosclerosis. J Dermatol Sci 2011;63:1-9. DOI: https://doi.org/10.1016/j.jdermsci.2011.04.007
Ethics Approval
How to Cite
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
PAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.